TrialCirculation2011

Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Burton E Sobel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.